Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Jul 19, 2022 5:20pm
195 Views
Post# 34835602

RE:RE:RE:RE:RE:RE:RE:With the Recent FDA Breakthrough Designation

RE:RE:RE:RE:RE:RE:RE:With the Recent FDA Breakthrough Designation
GeneralAladeen wrote: Question is why are we trading at $.48?? Is the market saying another financing is incoming? Would they do that again to the poor retailers that have been patiently waiting for 10 years?  I hope Friggin NOT!! 


I don't think the market is saying that because there is no market outside of 38 traders.  The price is what someone would like it to be.

Unfortunatelty however,  this (financing) is still a 32.8 % possibility.  Under the theory that past behaviour predicts future behaviour.

While Gorf doesn't care, I am very anti-dilution (at low SP's).  Most other non-insiders are as well.  Particularly the kind  of raises that are put out with uneven access and or when there is skewed amounts of skin in the game. And particulary when the overall quantity may be too high, if the story remains untold in the interim.

Ink a deal or two, and announce it, and it won't matter, and we'll all be good.


MM

<< Previous
Bullboard Posts
Next >>